Literature DB >> 7520872

Identification of imidazole as L-arginine-competitive inhibitor of porcine brain nitric oxide synthase.

B Mayer1, P Klatt, E R Werner, K Schmidt.   

Abstract

Imidazole acts as a heme-site inhibitor of nitric oxide synthase (NOS). We used this compound to investigate whether the substrate L-arginine binds directly to the heme or to a separate domain of brain NOS. Enzyme kinetic experiments showed that imidazole enhanced the apparent Km for L-arginine without affecting maximal enzyme activity, and binding studies revealed that the inhibitor displaced the radioligand NG-nitro-L-[3H]arginine in a concentration-dependent fashion. These results demonstrate that imidazole exerts its effects on NOS in an L-arginine-competitive manner and that the substrate site of the enzyme may be identical with the prosthetic heme group.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7520872     DOI: 10.1016/0014-5793(94)00766-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  DINITROBENZENES STIMULATE ELECTRON FLUX WITHIN NEURONAL NITRIC OXIDE SYNTHASE IN THE ABSENCE OF CALMODULIN.

Authors:  Chintamani N Joshi; David A Tulis; Richard T Miller
Journal:  Int J Biomed Res       Date:  2011

2.  The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.

Authors:  H M Siragy; R M Carey
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

3.  Inhibition of neuronal nitric oxide synthase by 6-nitrocatecholamines, putative reaction products of nitric oxide with catecholamines under oxidative stress conditions.

Authors:  A Palumbo; G Astarita; M d'Ischia
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

4.  Analysis of nitric oxide-cyclic guanosine monophosphate signaling during metamorphosis of the nudibranch Phestilla sibogae Bergh (Gastropoda: Opisthobranchia).

Authors:  Cory D Bishop; Anthony Pires; Shong-Wan Norby; Dmitri Boudko; Leonid L Moroz; Michael G Hadfield
Journal:  Evol Dev       Date:  2008 May-Jun       Impact factor: 1.930

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.